Immunic, Inc. (IMUX)

Immunic Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	35.67	46.67	106.75	86.86	127.45
Short-Term Investments	-	-	9.63	-	-
Cash & Short-Term Investments	35.67	46.67	116.37	86.86	127.45
Cash Growth	-23.58%	-59.89%	33.97%	-31.85%	333.97%
Other Receivables	0.68	2.48	2.66	2.15	1.64
Receivables	0.68	2.48	2.66	2.15	1.64
Prepaid Expenses	1.87	2.31	5.61	15.98	4.65
Other Current Assets	1.11	1.07	1.23	-	-
Total Current Assets	39.33	52.53	125.86	104.99	133.75
Property, Plant & Equipment	1.54	1.77	1.85	1.1	1.1
Goodwill	-	-	-	32.97	32.97
Other Long-Term Assets	-	-	0.04	0.04	0.04
Total Assets	40.87	54.3	127.75	139.1	167.86
Accounts Payable	7.85	5.1	4.28	3.75	3.7
Accrued Expenses	12.91	18.66	7.99	7.07	4.32
Current Portion of Leases	0.74	0.7	0.57	0.41	0.3
Other Current Liabilities	0.68	0.27	0.24	0.18	0.08
Total Current Liabilities	22.18	24.73	13.08	11.4	8.4
Long-Term Leases	0.26	0.64	0.99	0.58	0.68
Total Liabilities	22.44	25.37	14.07	11.99	9.08
Common Stock	0.01	0	0	0	0
Additional Paid-In Capital	525.61	436.06	427.93	324.24	266.82
Retained Earnings	-511.4	-410.89	-317.28	-196.87	-103.93
Comprehensive Income & Other	4.21	3.76	3.04	-0.25	-4.11
Total Common Equity	18.43	28.93	113.68	127.12	158.79
Shareholders' Equity	18.43	28.93	113.68	127.12	158.79
Total Liabilities & Equity	40.87	54.3	127.75	139.1	167.86
Total Debt	1	1.33	1.56	0.99	0.98
Net Cash (Debt)	34.66	45.34	114.81	85.87	126.48
Net Cash Growth	-23.55%	-60.51%	33.70%	-32.10%	338.41%
Net Cash Per Share	0.35	1.02	3.61	3.63	8.07
Filing Date Shares Outstanding	90.15	89.93	44.4	27.91	21.17
Total Common Shares Outstanding	90.15	45.18	39.31	26.34	21.17
Working Capital	17.16	27.81	112.79	93.59	125.35
Book Value Per Share	0.20	0.64	2.89	4.83	7.50
Tangible Book Value	18.43	28.93	113.68	94.15	125.82
Tangible Book Value Per Share	0.20	0.64	2.89	3.57	5.94

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q